Seeking Cures For
All 16 of our Taubman Scholars are practicing physicians whose patients are an ever-present reminder of the urgent need for new cures and therapies. Their areas of expertise range from stroke and heart attack to ALS to the vision loss that is a common complication of diabetes.
A number of our scientists are seeking new treatments for a range of cancers – including a common childhood cancer – while others are working to understand conditions like obesity and skin diseases.
In just three short years, Taubman Scholars have published 94 articles in leading scientific journals, and Taubman Institute support has led to 10 human clinical trials of new treatments for disease.
To read more about how each Scholar’s approach targets specific diseases, click on the links to their research outline.
Amyotrophic lateral sclerosis (ALS)
Diabetes and complications of diabetes
Heart attack and stroke
Motor neuron disease
Visiting Professor lecture to feature genetics expert
Brendan Lee, M.D., Ph.D., a genetics expert from Baylor College of Medicine, will headline the Pediatrics Research Symposium Oct. 6 at the U-M Medical School.
Click here for details and registration information.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.